PX1 Research supplies high-purity CJC-1295 (No DAC) directly to research laboratories in San Jose, CA, with same-day dispatch on orders placed before 12:00 PM PST Monday–Friday. Operating from regional fulfillment centers in California and Arizona, PX1 provides verified USA-synthesized peptides backed by lot-specific third-party RP-HPLC and mass spectrometry COAs, guaranteed >99% purity, and comprehensive endotoxin testing for seamless, customs-free domestic transit.
PX1 Research supplies high-purity CJC-1295 (No DAC) directly to research laboratories in San Jose, CA, with same-day dispatch on orders placed before 12:00 PM PST Monday–Friday. Operating from regional fulfillment centers in California and Arizona, PX1 provides verified USA-synthesized peptides backed by lot-specific third-party RP-HPLC and mass spectrometry COAs, guaranteed >99% purity, and comprehensive endotoxin testing for seamless, customs-free domestic transit.
Research facilities in San Jose and the broader South Bay area require reliable, rapid access to analytical-grade reagents without the administrative bottlenecks of international shipping. PX1 Research fulfills orders for CJC-1295 (No DAC) directly from fulfillment hubs in California and Arizona, ensuring standard transit to San Jose takes 1 to 2 business days. Every shipment contains lyophilized sequence-verified peptides engineered strictly for in vitro and preclinical research applications.
To safeguard batch integrity, PX1 Research provides batch-specific Certificate of Analysis (COA) documents for every order. Each lot undergoes rigorous analytical testing, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity quantification and Electrospray Ionization Mass Spectrometry (ESI-MS) for structural identification. Furthermore, chromogenic LAL assays ensure endotoxin levels remain below stringent research thresholds (<0.01 EU/mg).
By sourcing domestically within California, San Jose research institutions eliminate customs clearance delays, tariff complexities, and international supply chain volatility. Orders placed before 12:00 PM PST dispatch the same business day, packed in temperature-stable packaging designed to maintain chemical stability across Northern California transit corridors.
CJC-1295 (No DAC), also known as Modified GRF (1-29), is a 29-amino acid synthetic peptide analog of endogenous growth hormone-releasing hormone (GHRH). In preclinical models, GHRH analogs bind selectively to the GHRH receptor (GHRHR) on pituitary somatotropes. Unlike full-length GHRH (1-44), the truncated 1-29 sequence retains full receptor-binding affinity while incorporating specific amino acid substitutions at positions 2, 8, 15, and 27 to resist enzymatic degradation by dipeptidyl peptidase IV (DPP-IV).
In cell culture and animal tissue assays, CJC-1295 (No DAC) is studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream insulin-like growth factor 1 (IGF-1) levels for tissue repair research. Because it lacks the Drug Affinity Complex (DAC)—a maleimido derivative designed to bind serum albumin—CJC-1295 (No DAC) exhibits a shorter biological half-life (approximately 30 minutes) compared to its DAC-bound counterpart. This half-life allows researchers to simulate natural, pulsatile GH release kinetics in controlled laboratory settings.
Investigational protocols frequently combine GHRH analogs with secretagogues like Ipamorelin to observe potential synergistic receptor activation. For detailed sequence data, physical constants, and molecular weights, consult our comprehensive CJC-1295 (No DAC) technical guide or browse our complete selection of secretagogues in the full research peptide catalog.
San Jose stands as a primary hub for biotechnology, bioengineering, and academic research in Northern California. From university research laboratories around San Jose State University to commercial incubators in North San Jose and nearby South Bay corridors, investigators depend on fast reagent delivery to maintain project timelines. Interruptions in reagent supply can delay critical assays, stall grant deliverables, or compromise long-term cell culture studies.
Sourcing reagents from international suppliers introduces significant operational risks for San Jose facilities. Overseas shipments are frequently subject to unpredictable customs holds at entry ports such as San Francisco International Airport (SFO), potential border inspection seizures, and extended transit times in uncontrolled thermal environments. These delays elevate the risk of peptide degradation due to ambient heat or repeated freeze-thaw cycles prior to arrival.
PX1 Research mitigates these regional procurement risks by dispatching all domestic orders directly from facilities in California and Arizona. Utilizing established regional postal routes and expedited carrier networks, PX1 guarantees 1–2 day transit times to San Jose postal codes without international regulatory intervention. This domestic supply chain guarantees that high-purity reagents arrive intact, fully documented, and ready for immediate laboratory reconstitution.
Logistical efficiency is paramount when handling delicate synthetic peptides. PX1 Research operates an optimized distribution strategy tailored specifically to West Coast life science clusters. Orders directed to San Jose, Santa Clara, Sunnyvale, and surrounding South Bay municipalities leverage direct transit corridors from our local regional dispatch centers.
Orders placed before the 12:00 PM PST cutoff Monday through Friday are processed, packed, and shipped on the same day. Standard ground delivery from our California or Arizona hubs typically reaches San Jose addresses within 24 to 48 hours. Expedited priority transit options are also available at checkout for urgent laboratory requirements.
Every shipment is accompanied by end-to-end carrier tracking details, allowing lab managers and procurement specialists to monitor package movement from dispatch to delivery. This real-time visibility enables research personnel to coordinate incoming shipment reception and prepare appropriate cold-storage facilities prior to arrival.
Lyophilized (freeze-dried) peptides like CJC-1295 (No DAC) possess high inherent thermal stability when maintained in a dry state. However, during summer months in Northern California—where ambient transit temperatures through the Central Valley or South Bay can exceed 90°F—protective packaging protocols are essential to preserve primary peptide structure and prevent aggregation.
PX1 Research packages all CJC-1295 (No DAC) orders in temperature-buffered, protective insulated mailers designed to minimize exposure to extreme ambient heat. Lyophilization removes residual moisture, stabilizing the amide backbone and preventing hydrolytic cleavage during typical 24- to 48-hour transit windows.
Upon arrival at your San Jose facility, lyophilized vials should be unboxed immediately and transferred to refrigerated (2°C to 8°C) or frozen (-20°C) storage depending on intended experiment timelines. Prior to reconstitution with laboratory solvents (such as bacteriostatic water or sterile saline), vials should be allowed to reach room temperature to avoid moisture condensation inside the container.
The research peptide market contains numerous vendors operating with varying levels of quality control, transparency, and regulatory compliance. Conducting rigorous vendor qualification protects research budget integrity and prevents erroneous experimental data resulting from impure or mislabeled reagents.
When evaluating potential peptide suppliers for your San Jose laboratory, watch for the following major red flags:
1. Missing or Generic COAs: Suppliers that provide batch COAs without lot numbers, execution dates, or matching chromatograms are often reselling unverified imported batches without performing independent quality control.
2. Absence of Mass Spectrometry Data: HPLC alone confirms purity percentage but cannot verify exact molecular identity. Vendors that omit Mass Spectrometry (MS) analysis cannot guarantee sequence correctness.
3. Omission of Endotoxin Testing: In vitro cell culture and preclinical tissue models are extremely sensitive to lipopolysaccharide (LPS) contamination. Vendors failing to report endotoxin levels (<0.01 EU/mg) risk introducing cellular toxicity into your experimental models.
4. Claims of Human Use or Clinical Advice: Compliant research chemical suppliers strictly market products for laboratory research use only. Websites offering dosing calculators for personal consumption, clinical administration instructions, or medical claims operate outside regulatory frameworks.
5. Overseas Dropshipping: Vendors operating without domestic physical inventory often dropship directly from overseas manufacturers, leading to customs delays, variable transit conditions, and lack of lot traceability.
At PX1 Research, quality assurance is rooted in quantitative analytical metrics. Every production lot of CJC-1295 (No DAC) undergoes rigorous testing by independent, ISO/IEC 17025-accredited third-party laboratories within the United States. We do not rely on manufacturer self-attestation.
Purity is measured using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). A calibrated gradient mobile phase separates the target peptide sequence from synthesis side-products, truncated sequences, or residual protecting groups. PX1 guarantees that every lot of CJC-1295 (No DAC) achieves an analytical purity threshold exceeding 99.0%.
Identity verification is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS). The resulting mass spectrum must show an observed monoisotopic or average molecular weight matching the calculated theoretical mass of CJC-1295 (No DAC) (3357.93 g/mol) within strict instrument tolerances. Additionally, chromogenic LAL testing verifies that bacterial endotoxin concentrations remain below strict laboratory safety thresholds.
Researchers evaluating GHRH analogs must distinguish between CJC-1295 (No DAC) and CJC-1295 with DAC (Drug Affinity Complex). While both peptides share the Modified GRF (1-29) core sequence, their pharmacokinetic and pharmacodynamic profiles in experimental systems differ significantly.
CJC-1295 (No DAC) lacks the lysine linker and maleimido derivative that allows covalent binding to circulating serum albumin. Consequently, its plasma half-life in animal models is approximately 30 minutes, producing discrete, short-duration peaks in receptor activation. This makes CJC-1295 (No DAC) ideal for protocols seeking to mimic natural pulsatile signaling or investigate short-term biological responses.
Conversely, CJC-1295 with DAC binds covalently to endogenous albumin, extending its biological half-life to several days and producing sustained, continuous elevation of baseline growth hormone signaling. Choosing between these variants depends on whether your assay protocol requires rapid, clearance-sensitive pulsatile stimulation or prolonged receptor exposure. For assays exploring dual-receptor co-stimulation, researchers frequently pair CJC-1295 (No DAC) with ghrelin mimetics such as Ipamorelin.
Procurement managers and lab directors can use the structured criteria below to evaluate PX1 Research against standard domestic resellers and direct-from-overseas suppliers:
Purity Verification Criteria: PX1 Research provides lot-specific RP-HPLC chromatograms showing >99% purity for every batch. Standard resellers often display single static COAs, while overseas drop-shippers rarely offer verifiable purity data.
Structural Identity Testing: PX1 Research includes full ESI-MS mass spectrometry analysis per lot. Standard resellers rarely provide MS data, and overseas vendors rely solely on theoretical chemical structure documentation.
Endotoxin Testing Data: PX1 Research conducts LAL chromogenic assays ensuring <0.01 EU/mg per vial. Standard resellers and overseas vendors routinely omit endotoxin screening, creating contamination risks for sensitive assays.
Dispatch and Logistics: PX1 Research dispatches same-day from CA/AZ fulfillment centers with 1–2 day transit to San Jose. Standard resellers take 3–7 business days, while overseas shipping requires 10–25 days plus customs processing.
Regulatory Compliance and Traceability: PX1 Research maintains full batch-level lot traceability, strict laboratory research labeling, and complete regulatory compliance. Overseas vendors face frequent customs border seizures and lack batch accountability.
When you buy CJC-1295 (No DAC) for your San Jose laboratory from PX1 Research, your order is processed directly within our West Coast distribution system. Each package includes securely sealed 5 mg or 10 mg glass vials containing highly purified, lyophilized CJC-1295 (No DAC) powder, accompanied by lot-specific documentation accessible via digital QR code or direct download.
Orders submitted before 12:00 PM PST Monday through Friday qualify for same-day dispatch from our California and Arizona logistics facilities. Standard domestic carrier options ensure tracked delivery to San Jose facilities within 1 to 2 business days, preventing unnecessary environmental exposure during transit.
PX1 Research provides dedicated client support for research institutions, academic labs, and corporate biotechnology facilities across California. To view current batch availability, analytical COAs, and institutional volume options, order 5 mg or 10 mg vials of CJC-1295 (No DAC) directly from our verified online store today.
How fast will my CJC-1295 (No DAC) order arrive in San Jose, CA?
Orders placed before 12:00 PM PST Monday through Friday dispatch the same business day from our California or Arizona fulfillment centers. Delivery to San Jose addresses typically takes 1 to 2 business days via standard domestic carrier shipping.
Do you provide a COA for my specific CJC-1295 (No DAC) lot?
Yes. Every shipment of CJC-1295 (No DAC) includes access to a lot-specific Certificate of Analysis. The COA details independent third-party RP-HPLC purity results, mass spectrometry identity verification, and LAL endotoxin testing values.
Is CJC-1295 (No DAC) shipped on ice to San Jose?
CJC-1295 (No DAC) is shipped in a lyophilized (freeze-dried) state inside protective temperature-buffered packaging. Lyophilized peptides remain stable at ambient temperatures during 1 to 2 day transit windows, though immediate refrigeration is recommended upon arrival.
What is the purity level of PX1 Research CJC-1295 (No DAC)?
Every batch of CJC-1295 (No DAC) supplied by PX1 Research is verified by RP-HPLC to meet or exceed 99.0% purity, ensuring minimal truncated sequences or residual impurities in your research assays.
Are there customs risks when ordering peptides to San Jose from PX1?
No. Because PX1 Research ships directly from fulfillment centers located within the United States (California and Arizona), domestic shipments to San Jose bypass international customs entirely, eliminating border delays or import holdbacks.
What is the difference between CJC-1295 (No DAC) and Modified GRF (1-29)?
CJC-1295 (No DAC) and Modified GRF (1-29) refer to the exact same 29-amino acid tetrasubstituted peptide sequence. The 'No DAC' designation clarifies that the compound does not contain the Drug Affinity Complex extension.
How should CJC-1295 (No DAC) be stored upon arrival at our San Jose lab?
Lyophilized vials should be stored at 2°C to 8°C for short-term use or at -20°C for long-term storage. Once reconstituted with sterile laboratory solvent, solution aliquots should be kept frozen to prevent peptide oxidation or degradation.
Can I buy CJC-1295 (No DAC) in bulk for an institutional research facility in California?
Yes. PX1 Research supports institutional procurement officers and high-volume laboratories with volume pricing and batch-reservation options. Inquiries can be submitted directly through our bulk procurement portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.